SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Oct. 4, 2024 NEW YORK , Oct. 4, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sage Therapeutics, Inc. (NASDAQ: SAGE) between April 12, 2021 and July 23, 2024 , both dates inclusive (the "Class Period"), of the important October 28, 2024 lead plaintiff deadline. So what: If you purchased Sage securities during the Class...